|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,430.01 CNY | +0.42% |
|
-1.41% | -6.17% |
| 11-28 | Kweichow Moutai's board elects Chen Hua as chairman | RE |
| 11-25 | Declaration of Voting Results by Shanghai Wankexin Biotechnology | CI |
| Capitalization | 1,791B 253B 218B 204B 190B 351B 22,796B 382B 2,386B 921B 10,766B 951B 930B 39,366B | P/E ratio 2025 * |
19.5x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 1,588B 225B 193B 181B 169B 311B 20,214B 339B 2,115B 817B 9,547B 843B 825B 34,907B | EV / Sales 2025 * |
8.57x | EV / Sales 2026 * | 7.89x |
| Free-Float |
38.35% | Yield 2025 * |
3.92% | Yield 2026 * | 4.17% |
| 1 day | +0.42% | ||
| 1 week | -1.41% | ||
| Current month | -1.41% | ||
| 1 month | +0.70% | ||
| 3 months | -3.57% | ||
| 6 months | -5.55% | ||
| Current year | -6.17% |
| 1 week | 1,418.38 |  | 1,462.27 |
| 1 month | 1,418.38 | | 1,486.07 |
| Current year | 1,400 | | 1,657.99 |
| 1 year | 1,400 | | 1,657.99 |
| 3 years | 1,245.83 | | 1,935 |
| 5 years | 1,245.83 | | 2,627.88 |
| 10 years | 195.51 | | 2,627.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Wang
CEO | Chief Executive Officer | 53 | 18/08/2023 |
Jiang Yan
DFI | Director of Finance/CFO | 48 | 14/11/2021 |
Cong Ying Cai
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ya Lin You
CHM | Chairman | 56 | 19/03/2020 |
Tian Yong Guo
BRD | Director/Board Member | 56 | 15/06/2022 |
Shi Zhong Liu
BRD | Director/Board Member | 50 | 15/06/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | -1.41% | -5.36% | -14.11% | 253B | |
| +0.45% | -2.45% | -20.73% | -31.78% | 63.12B | |
| +0.48% | -6.30% | -8.41% | -31.15% | 31.41B | |
| +0.50% | -5.54% | -5.83% | -34.73% | 26.72B | |
| +0.85% | -5.05% | -26.15% | -57.39% | 13.39B | |
| +1.66% | +0.28% | -4.87% | +56.58% | 11.48B | |
| +0.98% | -6.20% | -15.54% | -36.20% | 10.51B | |
| +0.90% | -0.27% | -4.19% | -42.65% | 8.17B | |
| +0.53% | -3.73% | -23.51% | -17.84% | 6.42B | |
| +0.65% | -4.58% | -32.86% | -23.08% | 4.55B | |
| Average | +0.74% | -3.47% | -14.75% | -23.23% | 42.91B | |
| Weighted average by Cap. | +0.51% | -2.25% | -9.30% | -19.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 185B 26.22B 22.54B 21.11B 19.68B 36.35B 2,360B 39.53B 247B 95.35B 1,114B 98.4B 96.3B 4,075B | 198B 28.06B 24.12B 22.6B 21.06B 38.9B 2,525B 42.31B 264B 102B 1,193B 105B 103B 4,361B |
| Net income | 91.89B 13B 11.17B 10.47B 9.76B 18.02B 1,170B 19.6B 122B 47.27B 552B 48.78B 47.74B 2,020B | 98.48B 13.93B 11.97B 11.22B 10.46B 19.31B 1,254B 21.01B 131B 50.66B 592B 52.28B 51.17B 2,165B |
| Net Debt | -203B -28.69B -24.66B -23.1B -21.54B -39.78B -2,582B -43.27B -270B -104B -1,220B -108B -105B -4,459B | -226B -31.94B -27.45B -25.72B -23.97B -44.28B -2,874B -48.16B -301B -116B -1,358B -120B -117B -4,964B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 1,430.01 ¥ | +0.42% | 2,540,166 |
| 04/12/25 | 1,423.98 ¥ | -0.36% | 2,907,539 |
| 03/12/25 | 1,429.10 ¥ | -0.48% | 2,357,279 |
| 02/12/25 | 1,436.03 ¥ | -0.83% | 2,504,726 |
| 01/12/25 | 1,448.00 ¥ | -0.17% | 2,733,342 |
End-of-day quote Shanghai S.E., December 04, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition